Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03202277 · ClinicalTrials.gov registry record · NA
BeWell24: Smartphone-based Diabetes Prevention in the VA
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03202277 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 120 participants.
The verdict
NCT03202277, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Type 2 diabetes (T2D) is a national epidemic and current lifestyle programs and medications are not effectively managing the crisis. This project aims to test a novel smartphone-delivered intervention that simultaneously targets multiple health behaviors (i.e., sleep, sedentary behavior, physical activity,dietary intake) within clinical settings at a large Veteran Health Administration regional hospital. If effective, this project has potential for large-scale implementation nationwide through the VA healthcare system and broad applicability for other populations at T2D risk as well as other disorders.
Interventions
- BEHAVIORAL BeWell24 smartphone app
- BEHAVIORAL Health education app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-09-17 |
| Est. Completion | 2019-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03202277
The ClinicalTrials.gov registry entry for NCT03202277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BeWell24 smartphone app is the first listed.
NCT03202277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03202277 about?
NCT03202277 is a clinical study titled "BeWell24: Smartphone-based Diabetes Prevention in the VA". Type 2 diabetes (T2D) is a national epidemic and current lifestyle programs and medications are not effectively managing the crisis. This project aims to test a novel smartphone-delivered intervention that simultaneously targets multiple health behaviors (i.e., sleep, sedentary behavior, physical ac...
What is the current status of trial NCT03202277?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2017-09-17. Estimated completion is 2019-12-14.
What interventions are being tested in trial NCT03202277?
The interventions under investigation include: BeWell24 smartphone app (BEHAVIORAL), Health education app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03202277?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.